MStranslate

18/10/2025

New research from scientists at the Université de Genève and Hôpitaux Universitaires de Genève has identified a potential avenue to develop multiple sclerosis treatments that have less side-effects.

A promising target for multiple sclerosis A team from UNIGE and HUG has discovered a subgroup of immune cells particularly involved in the disease, paving the way for more precise treatments and avoiding certain side effects. © iStock. Representation of a nerve cell. In yellow, the myelin sheaths a...

17/10/2025

Patient Community Day 2025 in Barcelona communicated outcomes of the European Committee for Treatment & Research in Multiple Sclerosis conference to people living with multiple sclerosis around the world. After the event, Brett sat down with Julie Petrin (MS Canada and a person living with MS) and Non Helena Smit (Multiple Sclerosis South Africa (MSSA)) to talk about their experience. Listen below!

Patient Community Day 2025 set a new attendance record, highlighting the growing desire among people living with MS to connect with experts leading the charge in understanding the disease and advancing effective treatments. After the event wrapped up in Barcelona, host Brett Drummond caught up with....

15/10/2025

A newly published study from the Πανεπιστήμιο Αθηνών - University of Athens has found that people living with multiple sclerosis have a higher risk of migraines than the general population and experience "more frequent, longer, and more intense headache attacks". While not a commonly discussed symptom of MS, these results indicate that more research is needed to understand the underlying causes and develop better management strategies.

14/10/2025

New research from the UC Riverside has shed light on why some people living with multiple sclerosis may experience seizures. These findings provide opportunities for targeted therapies to be explored, which could help manage this debilitating symptom in the future.

Study may explain why some people living with multiple sclerosis experience epileptic seizures

13/10/2025

Replays of ECTRIMS Patient Community Day are now available! Hear from leading researchers and neurologists on the latest updates from the European Committee for Treatment & Research in Multiple Sclerosis 2025 conference. The discussion included topics such as CAR T-cells, artificial intelligence, cognition, smouldering MS, rehabilitation and much more. You can access all sessions here:

https://www.youtube.com/playlist?list=PL7IePEgWfHEeKf4wYRBJJRVaVK0oNqT4y

10/10/2025

Yesterday was World Mental Health Day - a powerful reminder that mental wellbeing matters every single day of the year. For people living with multiple sclerosis, the emotional and psychological challenges can be just as real as the physical ones. Higher rates of anxiety, depression and mood changes are common and they deserve just as much attention and care.

Let’s continue to support conversations about mental health in MS. Not just on one day, but every day.

07/10/2025

We’re planning a series of Facebook Live broadcasts for the rest of the year, focusing on some of the exciting research and discussions from ECTRIMS 2025. Before we lock in the schedule, we want to hear from you! What topics are you most interested in? Share your thoughts in the comments and help shape our next conversations.

01/10/2025

A small study has found that aerobic exercise may help to promote myelin repair in people living with multiple sclerosis. As we continue to search for remyelination therapies, this suggests that supporting metabolic health may help improve the effectiveness of these treatments - though more trials are needed to understand this interaction. The work was conducted by researchers at Oregon Health & Science University (OHSU) and presented at the European Committee for Treatment & Research in Multiple Sclerosis (ECTRIMS) 2025 conference.

30/09/2025

A large study, led by researchers at Monash University, has found that menopause does not increase the risk of disability progression in women living with multiple sclerosis. Exploring how changes in s*x hormone levels across life influence disease activity in MS remains a major focus of research and this study marks another important step forward.

The largest study of its kind found menopause wasn’t associated with increased disability risk in women with MS.

29/09/2025

Another step forward for myelin repair research! The Cambridge Clinical Multiple Sclerosis Research Group shared the results of their successful CCMR Two trial with metformin and clemastine at ECTRIMS 2025. The findings showed that these drugs can encourage myelin repair in people with MS, though the effect was modest. Importantly, no improvements in function were seen and some mild side effects (including diarrhoea and fatigue) were reported. For this reason, the team advised against using these medications outside of a trial setting.

This is now the third study to demonstrate that repairing myelin is possible, an incredibly encouraging sign that effective remyelination therapies may not be too far away. Congratulations to everyone involved in driving this groundbreaking research forward!

24/09/2025

Day 1 of ECTRIMS 2025 has finished in Barcelona! The keynote lecture today focused on cognitive issues in multiple sclerosis. While we will do a Facebook Live on this after the conference, a key message was that researchers are convinced that the preservation of cognitive function in people living with MS is a realistic goal.

We also heard a lot about how CAR T-cells remain a promising new treatment approach for MS, though more clinical trials are needed to really understand the benefits and safety risks.

Lastly, sessions discussed how MS nurses are working to engage with people living with MS to improve their health literacy and to ensure that shared decision making happens throughout the course of the disease.

All of these topics will be discussed on Patient Community Day and it is not too late to register (www.ectrimspatientcommunity.eu/registration)

22/09/2025

We have arrived in Barcelona for ECTRIMS 2025! Stay tuned over the next week as we bring you the highlights of the largest multiple sclerosis research conference in the world, hosted by the European Committee for Treatment & Research in Multiple Sclerosis.

It is also not too late to register for Patient Community Day (www.ectrimspatientcommunity.eu/registration) - make sure you register to be made aware when the livestream and replay videos are available.